ES469937A1 - Procedimiento para preparar una nueva cepa del virus de la rabia. - Google Patents

Procedimiento para preparar una nueva cepa del virus de la rabia.

Info

Publication number
ES469937A1
ES469937A1 ES469937A ES469937A ES469937A1 ES 469937 A1 ES469937 A1 ES 469937A1 ES 469937 A ES469937 A ES 469937A ES 469937 A ES469937 A ES 469937A ES 469937 A1 ES469937 A1 ES 469937A1
Authority
ES
Spain
Prior art keywords
novel
rabies virus
virus strain
virus vaccine
rabies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469937A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES469937A1 publication Critical patent/ES469937A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
ES469937A 1977-01-26 1978-05-17 Procedimiento para preparar una nueva cepa del virus de la rabia. Expired ES469937A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3258/77A GB1596653A (en) 1977-01-26 1977-01-26 Vaccine

Publications (1)

Publication Number Publication Date
ES469937A1 true ES469937A1 (es) 1978-12-16

Family

ID=9754946

Family Applications (2)

Application Number Title Priority Date Filing Date
ES466359A Expired ES466359A1 (es) 1977-01-26 1978-01-26 Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.
ES469937A Expired ES469937A1 (es) 1977-01-26 1978-05-17 Procedimiento para preparar una nueva cepa del virus de la rabia.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES466359A Expired ES466359A1 (es) 1977-01-26 1978-01-26 Procedimiento para preparar vacunas vivas e inactivas del virus de la rabia.

Country Status (20)

Country Link
US (2) US4320115A (es)
JP (2) JPS5394084A (es)
AT (1) AT368005B (es)
BE (1) BE863368A (es)
CA (1) CA1112167A (es)
CH (2) CH658192A5 (es)
DE (1) DE2803240B2 (es)
DK (1) DK36378A (es)
ES (2) ES466359A1 (es)
FI (1) FI59812C (es)
FR (1) FR2378859B1 (es)
GB (1) GB1596653A (es)
IE (1) IE46498B1 (es)
IT (1) IT1192756B (es)
LU (1) LU78951A1 (es)
NL (1) NL174371C (es)
NO (1) NO780156L (es)
PT (1) PT67554B (es)
SE (2) SE444453B (es)
ZA (1) ZA78421B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
EP0100752A3 (de) * 1982-08-04 1985-04-17 Veterinär-Bakteriologisches Institut der Universität Bern Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
DE3526809A1 (de) * 1985-07-26 1987-04-02 Behringwerke Ag Tollwut-lebendimpfstoff
CA1249518A (en) * 1985-09-06 1989-01-31 David Johnston Oral immunization of mammals
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
AU2359195A (en) * 1994-04-19 1995-11-10 Thomas Jefferson University Viral ribonucleocapsid as an immunological enhancer
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
US20030118628A1 (en) * 2001-04-05 2003-06-26 Tutuncu Nurhan Pinar Confectionery product having a salivation region and an oral comfort region
CN112342185B (zh) * 2020-11-11 2022-12-02 深圳市卫光生物制品股份有限公司 一种鸡胚细胞狂犬病病毒的生物反应器工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015262A (en) * 1962-02-09 1965-12-31 Nat Res Dev Virus culture
US3255080A (en) * 1962-08-06 1966-06-07 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
FR1567869A (es) * 1967-06-22 1969-05-23
US4014991A (en) * 1976-01-23 1977-03-29 The United States Of America As Represented By The Department Of Health, Education And Welfare Oral rabies immunization of carnivores

Also Published As

Publication number Publication date
SE443924B (sv) 1986-03-17
JPS6225127B2 (es) 1987-06-01
IE780161L (en) 1978-07-26
LU78951A1 (fr) 1979-09-06
ES466359A1 (es) 1978-10-01
SE7800781L (sv) 1978-07-27
DE2803240A1 (de) 1978-08-10
ATA52678A (de) 1982-01-15
CH659084A5 (de) 1986-12-31
PT67554B (en) 1979-06-18
GB1596653A (en) 1981-08-26
IT7867143A0 (it) 1978-01-25
NL7800708A (nl) 1978-07-28
SE8201768L (sv) 1982-03-19
FI780184A (fi) 1978-07-27
CA1112167A (en) 1981-11-10
NO780156L (no) 1978-07-27
FI59812C (fi) 1981-10-12
FR2378859B1 (es) 1980-08-29
BE863368A (fr) 1978-07-26
US4320115A (en) 1982-03-16
JPS5877822A (ja) 1983-05-11
NL174371C (nl) 1984-06-01
CH658192A5 (de) 1986-10-31
DE2803240B2 (de) 1980-08-07
FI59812B (fi) 1981-06-30
IE46498B1 (en) 1983-06-29
IT1192756B (it) 1988-05-04
ZA78421B (en) 1979-01-31
US4400472A (en) 1983-08-23
PT67554A (en) 1978-02-01
JPS5394084A (en) 1978-08-17
AT368005B (de) 1982-08-25
SE444453B (sv) 1986-04-14
JPS637754B2 (es) 1988-02-18
FR2378859A1 (es) 1978-08-25
DK36378A (da) 1978-07-27

Similar Documents

Publication Publication Date Title
ES8502871A1 (es) Procedimiento de obtencion de vacunas de bronquitis infecciosa para aves de corral
GB1457382A (en) Process for preparing live varticella vaccines
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
ES462588A1 (es) Procedimiento para la obtencion de vacunas, por tratamiento de microorganismos en un campo electrico de corriente alter-na.
GB2079786B (en) Production of viral antigens
IE883839L (en) Vaccines
GB1501724A (en) Highly attenuated cytomegalovirus vaccine and production thereof
AU8014691A (en) Vaccine against lyme disease and a challenge model for evaluating vaccine efficiency
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
ES8107025A1 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
JPS5527178A (en) Live influenza virus vaccine
EP0023731A3 (en) Process for the preparation of polyvalent virus vaccines in a single cell system, such polyvalent vaccines and their application
NZ216119A (en) Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus
AU3532089A (en) A pasteurella vaccine
ZA805849B (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
ES476703A1 (es) Procedimiento para preparar una heterovacuna para el trata -miento terapeutico del sindrome de los triconomas.
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
NZ222766A (en) Aids virus antigens: env/gag polypeptides: production by genetic engineering techniques: vaccines, and methods of diagnostic testing
HUT52703A (en) Process for producing living vaccines of newcastle disease virus
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
GB1436323A (en) Cell and virus culture systems

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19931122